Skip to main content
Tulane Home Tulane Home

Tulane Cancer Center ~ Clinical Trials ~ Myeloma

ABBVIE M13
A Phase 1/2 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma
More Information

MERCK 3475-183 A Phase III Study of Pomalidomide and Low-Dose Dexamethasone With or Without Pembrolizumab (MK3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM). (KEYNOTE 183)
More Information
ON HOLD

MERCK 3475-185
A Plase III Study of Lenalidomide and Low-Dose Dexamethasone With or Without Pembrolizumab (MK3475) in Newly Diagnosed and Treatment Naive Multiple Myeloma (KEYNOTE 185)
More Information
ON HOLD